Fig 5 Data. by Kevin D. Gaitonde (15411707)

Subjects:

ALDH2 inhibitors decrease stroma-induced ALDH activity in AML cells and sensitize them to chemotherapy. by Bin Yuan (19897)

MigC interacts with and decreases the activity of MurD. by Jeanette M. Critchlow (21553796)

<i>CYB561</i> knockdown decreased the survival, proliferation, and migration rates of PC-3 cells. by Romie Angelo G. Azur (18547651)

Deoxysphingolipids – atypical skeletal muscle lipids related to insulin resistance in humans that decrease insulin sensitivity in vitro by Simona Zarini (15332025)

SCS DKO parasites have decreased mitochondrial ATP content, but are capable of ATP import and ATP hydrolysis. by Gergana Taleva (17131885)

Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels. by Hiromi Yamaguchi (2396248)

Subjects:

LC-IMS-CID-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

“…The lysophospholipids were the most decreased class of lipids, and free fatty acids and ceramides important in barrier formation were also decreased. …”

Ambient vs. classroom daily average PM_2.5 concentrations. by Alexandra Azevedo (14203296)

Data_Sheet_1_Pulmonary inflammation decreases with ultra-protective ventilation in experimental ARDS under VV-ECMO: a positron emission tomography study.docx by Guillaume Deniel (17990323)

“…Animals were randomized to receive either UPV (V_T 1 mL.kg⁻¹, positive end-expiration pressure [PEEP] set to obtain plateau pressure between 20 and 25 cmH₂O and respiratory rate [RR] at 5 min⁻¹ under VV-ECMO) or PV (V_T 6 mL.kg⁻¹, PEEP set to obtain plateau pressure between 28 and 30 cmH₂O and RR at 25 min⁻¹) during 4 h. …”

Mean productivity change in all 5 countries. by Wasi Ul Hassan Shah (8605236)

Cumulative distribution of EQ-5D-3L utilities decreasingly ordered before and after the onset of cutaneous leishmaniasis symptoms. by Janaína de Pina Carvalho (12152812)

Fig 5 - by Dennis Ochola (11626912)

Subjects:

Primary and secondary outcomes of the randomized clinical trial groups at 3 months and 12 months. by Teemu P. Hevonkorpi (11577571)

Subjects:

Baseline characteristics of 291 patients by randomization group. by Teemu P. Hevonkorpi (11577571)

Subjects:

Adverse events at 12-month follow-up by study group. by Teemu P. Hevonkorpi (11577571)

Subjects:

Participant flow diagram of the DRIFT trial. by Teemu P. Hevonkorpi (11577571)

Subjects:

Between-group differences of mean PRWE with 95% confidence intervals in primarily malaligned DRFs and early malaligned DRFs at 3-month and 12-month follow-up. by Teemu P. Hevonkorpi (11577571)

Subjects:

The mean blood ingestion ratio of uninfected <i>Rhodnius prolixus</i> blood-fed at different developmental stages and ambient temperatures. by Henri Loshouarn (17896676)

“…Additionally, the triatomines kept at 26°C had the lowest blood ingestion ratio of all temperature treatments (comparison with: the 24°C treatment, p = 2.1e-05; the 28°C treatment, p = 2.5e-06; and the 30°C treatment, p = 0.00022; n = 111 for all comparisons). …”

Decreased peritumoral myofibroblasts in the MC38 S.C. tumors of <i>S100a4-Cre; Ext1</i>^<i>f/f</i> mice. by Ayumi Niwa (6256790)